 |
United States Code (Last Updated: May 24, 2014) |
 |
Title 21. FOOD AND DRUGS |
|
|
Chapter 9. FEDERAL FOOD, DRUG, AND COSMETIC ACT |
|
|
SubChapter V. DRUGS AND DEVICES |
|
|
Part A. Drugs and Devices |
| § 351. Adulterated drugs and devices |
| § 352. Misbranded drugs and devices |
| § 353. Exemptions and consideration for certain drugs, devices, and biological products |
| § 353a. Pharmacy compounding |
| § 353a–1. Enhanced communication |
| § 353b. Outsourcing facilities |
| § 353c. Prereview of television advertisements |
| § 354. Veterinary feed directive drugs |
| § 355. New drugs |
| § 355–1. Risk evaluation and mitigation strategies |
| § 355a. Pediatric studies of drugs |
| § 355b. Adverse-event reporting |
| § 355c. Research into pediatric uses for drugs and biological products |
| § 355c–1. Report |
| § 355d. Internal committee for review of pediatric plans, assessments, deferrals, deferral extensions, and waivers |
| § 355e. Pharmaceutical security |
| § 355f. Extension of exclusivity period for new qualified infectious disease products |
| § 356. Expedited approval of drugs for serious or life-threatening diseases or conditions |
| § 356–1. Accelerated approval of priority countermeasures |
| § 356a. Manufacturing changes |
| § 356b. Reports of postmarketing studies |
| § 356c. Discontinuance or interruption in the production of life-saving drugs |
| § 356c–1. Annual reporting on drug shortages |
| § 356d. Coordination; task force and strategic plan |
| § 356e. Drug shortage list |
| § 356f. Hospital repackaging of drugs in shortage |
|
§ 357. Repealed. Pub. L. 105–115, title I, § 125(b)(1), |
| § 358. Authority to designate official names |
| § 359. Nonapplicability of subchapter to cosmetics |
| § 360. Registration of producers of drugs or devices |
| § 360a. Clinical trial guidance for antibiotic drugs |
| § 360a–1. Clinical trials |
| § 360b. New animal drugs |
| § 360c. Classification of devices intended for human use |
| § 360c–1. Reporting |
| § 360d. Performance standards |
| § 360e. Premarket approval |
| § 360e–1. Pediatric uses of devices |
| § 360f. Banned devices |
| § 360g. Judicial review |
| § 360g–1. Agency documentation and review of significant decisions regarding devices |
| § 360h. Notification and other remedies |
| § 360h–1. Program to improve the device recall system |
| § 360i. Records and reports on devices |
| § 360j. General provisions respecting control of devices intended for human use |
| § 360k. State and local requirements respecting devices |
| § 360l. Postmarket surveillance |
| § 360m. Accredited persons |
| § 360n. Priority review to encourage treatments for tropical diseases |
| § 360n–1. Priority review for qualified infectious disease products |